Drug Repurposing Market
Drug Repurposing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Drug Repurposing Market Size and Growth
The drug repurposing market is experiencing significant growth, driven by rising R&D costs and the urgent need for rapid therapeutic solutions. Valued at approximately $30 billion in 2023, it is projected to expand at a CAGR of 8% through 2030, reflecting increased investments and innovations in drug development strategies.
Companies Covered
(Covid 19 Impact Covered)
◍ Pfizer
◍ Roche
◍ Novartis AG
◍ Abbott Healthcare
◍ Johnson & Johnson
◍ Sandoz
◍ Mylan Inc.
◍ Teva Pharmaceuticals
The Drug Repurposing Market features major players like Pfizer, Roche, Novartis, Abbott, Johnson & Johnson, Sandoz, Mylan, and Teva. These companies advance the market through innovative studies, collaborations, and technology. Their substantial sales revenue supports research, enhancing drug availability and accelerating treatment options for various diseases.
- Pfizer: ~$51.3 billion
- Roche: ~$63.4 billion
- Johnson & Johnson: ~$93.8 billion
- Novartis AG: ~$51.6 billion
Request Sample Report
Market Segmentation
By Application
Cardiovascular Disorders ◍ Central Nervous Disorders
Oncology
Others
Request Sample Report
By Product
Intravenous
Oral
Market Growth
Request Sample Report
$ 37.59 Billion
